AI Model for Cervical Cancer Detection From Colposcopy Images
Cervical cancer is a significant health issue, particularly in low-income countries, where late diagnosis and limited access to screenings contribute to high mortality rates. This study aims to develop and evaluate an artificial intelligence (AI) model to analyze colposcopic images for detecting cervical cancer more ac
| Condition(s) | Uterine Cervical Neoplasms |
|---|---|
| Status | Recruiting |
| Study type | Observational |
| Summary | Cervical cancer is a significant health issue, particularly in low-income countries, where late diagnosis and limited access to screenings contribute to high mortality rates. This study aims to develop and evaluate an artificial intelligence (AI) model to analyze colposcopic images for detecting cervical cancer more accurately and efficiently. Colposcopy, a procedure used to examine the cervix for signs of cancer, relies heavily on doctors' expertise, leading to inconsistent results. The current gold standard, colposcopy-directed biopsy, is invasive and can cause complications. The hypothesis is that an AI model can outperform traditional methods in identifying cervical abnormalities, providing a reliable and scalable solution for early detection, especially in underserved areas. By automa |
| Who can participate | Inclusion Criteria: * Female patients of age 18 years or older can be selectedas subjects. * Individuals willing to participate in cervical cancerscreening. * Availability for colposcopic examination. * Women with no history of hysterectomy (total removalof the uterus). * Women with no current or prior diagnosis of cervicalcancer. * Availability of relevant medical records forconfirmation and comparison purposes. Exclusion Criteria: * Pregnant women, given the potential impact onscreening results and the need for specialconsiderations during pregnancy. * Individuals with severe medical conditions orcircumstances that may make colposcopic examinationinappropriate or unsafe. * Patients with conditions that could interfere with theaccuracy of the screening results, such as severevaginal bleed |
| Ages | 18 Years |
| Sex | Female |
| Accepts healthy volunteers | Yes |
| Lead sponsor | Bangladesh University of Engineering and Technology |
| Locations | Dhaka, Bangladesh |
| Start date | 2024-01-11 |
| NCT ID | NCT06644248 |
| Official listing | https://clinicaltrials.gov/study/NCT06644248 |